w66最给利老牌
w66最给利老牌:About Us
w66最给利老牌:About Sino Biopharm
w66最给利老牌:Board of Directors
w66最给利老牌:Senior Management
R&D
R&D Team
w66最给利老牌:Products
w66最给利老牌:Product List
w66最给利老牌:Sustainability
ESG Governance
w66最给利老牌:ESG Management Practices
w66最给利老牌:ESG Reports
w66最给利老牌:Investors
w66最给利老牌:Information Disclosure
w66最给利老牌:Corporate Governance
w66最给利老牌:Presentation
w66最给利老牌:Investor FAQ
Notices
w66最给利老牌:News
w66最给利老牌:Press Releases
w66最给利老牌:Contact
CN
EN
Investors
Home
>
w66最给利老牌:Investors
>
Information Disclosure
w66最给利老牌:
Information Disclosure
w66最给利老牌:
Corporate Governance
w66最给利老牌:
Presentation
w66最给利老牌:
Investor FAQ
w66最给利老牌:
Notices
Information Disclosure
Annual Report 2008
2009.04.21
Interim Report 2008
2008.09.17
2007 Annual Report
2008.04.08
Interim Report 2007
2007.09.19
Annual Report
2007.04.25
Interim Report
2006.09.26
Annual Report
2006.05.03
Interim Report
2005.09.30
首页
上一页
46
47
48
49
50
51
52
尾页
下一页